» Articles » PMID: 35191632

Fresh Elective Frozen Embryo Transfer: Cumulative Live Birth Rates of 7,236 IVF Cycles

Overview
Date 2022 Feb 22
PMID 35191632
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether elective frozen embryo transfer (eFET), or the 'freeze-all' strategy, associated with better cumulative clinical outcomes compared with fresh embryo transfer (ET).

Methods: A total of 7,236 IVF cycles that were followed by a fresh ET or eFET between 2013 and 2017. The patients were subjected to controlled ovarian stimulation (COS) with a gonadotropin-releasing hormone (GnRH) antagonist protocol and cleavage-stage ET. Embryo cryopreservation was performed on day 3 by vitrification using an open system. A comparison of cumulative outcomes between the eFET (n=4,065cycles) and the fresh ET groups (n=3,171cycles) were performed. The analysis was performed in four groups of patients based on the number of retrieved oocytes: Group 1: poor responders (1-3 oocytes); Group 2: suboptimal responders (4-9 oocytes); Group 3: normal responders (10-15 oocytes); and Group 4: hyper-responders (>15 oocytes). The primary outcome was the cumulative live birth rate (CLBR) per stimulated cycle.

Results: There were a total of 10,283 ETs (n=5,639 eFET group; n=4,644 fresh group). The freeze-all strategy is associated with improved CLBRs in normal and hyper-responders, but not in suboptimal and poor responders. In Group 1, there were 351 IVF cycles and 387 ETs in total, and the CLBR was 14.3% and 17.7% (p=0.584) for the eFET and fresh group, respectively. In Group 2, there were 2,074 IVF cycles and 2,465 ET in total, and the CLBR was 25.1% and 23.3% (p=0.083) in the eFET and fresh group, respectively. There was a significant difference in the CLBR in Groups 3 and 4, favouring the eFET strategy. In Group 3, 2226 IVF cycles and 3243 ET were performed. The CLBR was 40.5% in the eFET and 36.6% in the fresh group (p<0.001). In Group 4, there were 2547 IVF cycles and 3,188 ET in total, and the CLBR was 52.2% and 47.7% (p<0.001) in the eFET and fresh group, respectively. The number needed to treat to achieve one additional live birth was 25.9 in Group 3 and 22.3 in Group 4.

Conclusions: The implementation of the freeze-all strategy should be individualized. The freeze-all strategy is associated with improved CLBRs in normal and hyper-responders, but not in suboptimal and poor responders.

Citing Articles

Does double cryopreservation as well as double biopsy affect embryo viability and clinical outcomes? Evidence from a systematic review of the literature.

Bartolacci A, Vitiello C, de Girolamo S, Papaleo E, Pagliardini L J Assist Reprod Genet. 2025; .

PMID: 39893354 DOI: 10.1007/s10815-025-03398-5.


To Assess or Not to Assess: Reconsidering Day 3 Embryo Quality in Planned Freeze-All Blastocyst Cycles.

Bartolacci A, Marzanati D, Barbagallo B, Solano Narduche L, DAlessandro G, Esposito S J Pers Med. 2024; 14(6).

PMID: 38929846 PMC: 11204659. DOI: 10.3390/jpm14060624.


Good practice recommendations on add-ons in reproductive medicine†.

Lundin K, Bentzen J, Bozdag G, Ebner T, Harper J, Le Clef N Hum Reprod. 2023; 38(11):2062-2104.

PMID: 37747409 PMC: 10628516. DOI: 10.1093/humrep/dead184.


A randomised control trial on oral dydrogesterone micronized vaginal progesterone pessary for luteal phase support in fertilization cycles.

Ikechebelu J, Dim C, Eleje G, Joe-Ikechebelu N, Okpala B, Okam P J Med Life. 2023; 16(1):62-69.

PMID: 36873122 PMC: 9979184. DOI: 10.25122/jml-2022-0131.

References
1.
Ubaldi F, Bourgain C, Tournaye H, Smitz J, VAN Steirteghem A, Devroey P . Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997; 67(3):521-6. DOI: 10.1016/s0015-0282(97)80080-5. View

2.
Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R . Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. 2012; 99(1):156-162. DOI: 10.1016/j.fertnstert.2012.09.003. View

3.
Polyzos N, Sunkara S . Sub-optimal responders following controlled ovarian stimulation: an overlooked group?. Hum Reprod. 2015; 30(9):2005-8. DOI: 10.1093/humrep/dev149. View

4.
Roque M, Haahr T, Esteves S, Humaidan P . The 'Big Freeze': freeze-all should not be used for everyone. Hum Reprod. 2018; 33(8):1577-1578. DOI: 10.1093/humrep/dey218. View

5.
Ferraretti A, Gianaroli L, Magli C, Fortini D, Selman H, Feliciani E . Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod. 1999; 14(6):1457-60. DOI: 10.1093/humrep/14.6.1457. View